IT1239283B - Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare. - Google Patents

Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.

Info

Publication number
IT1239283B
IT1239283B IT22312A IT2231289A IT1239283B IT 1239283 B IT1239283 B IT 1239283B IT 22312 A IT22312 A IT 22312A IT 2231289 A IT2231289 A IT 2231289A IT 1239283 B IT1239283 B IT 1239283B
Authority
IT
Italy
Prior art keywords
prevention
treatment
agent alone
ventricular arrhythmia
antiarrhythmic drug
Prior art date
Application number
IT22312A
Other languages
English (en)
Other versions
IT8922312A1 (it
IT8922312A0 (it
Inventor
Mauro Grossoni
Patrizia Salvati
Giorgio Ukmar
Lorenzo Vaga
Carlo Patrono
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Priority to IT22312A priority Critical patent/IT1239283B/it
Publication of IT8922312A0 publication Critical patent/IT8922312A0/it
Priority to JP2299683A priority patent/JPH03169826A/ja
Priority to DE4035226A priority patent/DE4035226A1/de
Publication of IT8922312A1 publication Critical patent/IT8922312A1/it
Application granted granted Critical
Publication of IT1239283B publication Critical patent/IT1239283B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT22312A 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare. IT1239283B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT22312A IT1239283B (it) 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.
JP2299683A JPH03169826A (ja) 1989-11-08 1990-11-05 心室不整脈の予防及び治療のためのムスカリン作用薬の使用
DE4035226A DE4035226A1 (de) 1989-11-08 1990-11-06 Verwendung eines als muscarinagonist wirkenden mittels zur praevention und behandlung ventrikulaerer arrhytmie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22312A IT1239283B (it) 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.

Publications (3)

Publication Number Publication Date
IT8922312A0 IT8922312A0 (it) 1989-11-08
IT8922312A1 IT8922312A1 (it) 1991-05-08
IT1239283B true IT1239283B (it) 1993-10-19

Family

ID=11194522

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22312A IT1239283B (it) 1989-11-08 1989-11-08 Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.

Country Status (3)

Country Link
JP (1) JPH03169826A (it)
DE (1) DE4035226A1 (it)
IT (1) IT1239283B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016198342A1 (de) * 2015-06-09 2016-12-15 Bayer Pharma Aktiengesellschaft Positiv allosterische modulatoren des muskarinergen m2 rezeptors

Also Published As

Publication number Publication date
IT8922312A1 (it) 1991-05-08
JPH03169826A (ja) 1991-07-23
IT8922312A0 (it) 1989-11-08
DE4035226A1 (de) 1991-05-16

Similar Documents

Publication Publication Date Title
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
IL81672A0 (en) N,n'-dihalo-2-imidazolidinones and their use as disinfectants
IT1229195B (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
EP0331620A3 (en) Agent for the treatment of parkinson's disease
Kaminsky Aspects of harmony, rhythm and form in Schumann's Papillons, Carnaval and Davidsbündlertänze
OA09194A (en) "Insecticidal treatment and compositions therefor".
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
IT8721687A0 (it) Derivati dell'ossima della 1,2,5,6-tetraidropiridin-3-carbossa ldeide, loro procedimento di preparazione e loro impiego come sostanze medicinali.
IT1239283B (it) Uso di un agente muscarinico da solo o insieme ad un noto farmaco antiaritmico per la prevenzione e/o il trattamento dell'aritmia ventricolare.
ZA816515B (en) Pharmaceutical compositions, effective against coronary heart disease and hypertension
DE69011356D1 (de) 6'Deoxy-6'-halogenoneplanosin A und dessen Herstellung.
IT1244562B (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino.
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
RU93035343A (ru) Вещество, обладающее антиагрегантной активностью
RU99107944A (ru) Лечебное средство прямого антикоагулянтного и фибринолитического действия
RU97108900A (ru) Применение этимизола в качестве антиаритмического средства для предупреждения желудочковой экстрасистолии у больных ибс
Johnson Attributions, stereotypes and the achievement of the elderly
IT8820571A0 (it) Agente antiinfiammatorio per la terapia dell'ipertrofia prostatica, sua preparazione e relative composizioni farmaceutiche.
IT1201431B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10 triacetossi-1,8,9 antracene
IT8822256A0 (it) Associazione farmaceutica ad attivita' antitrombotica
ITMI930453A0 (it) Composizione farmaceutica avente attivita' antiasmatica
ITFI930001A1 (it) Medicamento per il trattamento dell'asma.
IT8748222A0 (it) Tropina da solo o in combinazione uso di un medicamento a base di un con l'ormone follicolo-stimolante fattore di rilascio della somatonel trattamento della sterilita

Legal Events

Date Code Title Description
0001 Granted